BIFIDO Co., Ltd. (KOSDAQ:238200)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,830.00
-40.00 (-1.39%)
At close: Apr 28, 2026
-13.98%
Market Cap 23.15B
Revenue (ttm) 19.68B
Net Income (ttm) -192.74M
Shares Out 8.18M
EPS (ttm) -24.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 14,115
Average Volume 20,836
Open 2,850.00
Previous Close 2,870.00
Day's Range 2,815.00 - 2,910.00
52-Week Range 2,460.00 - 4,390.00
Beta 1.00
RSI 48.17
Earnings Date May 14, 2026

About BIFIDO

BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1999
Employees 83
Stock Exchange KOSDAQ
Ticker Symbol 238200
Full Company Profile

Financial Performance

In 2025, BIFIDO's revenue was 19.68 billion, an increase of 59.34% compared to the previous year's 12.35 billion. Losses were -192.74 million, -96.43% less than in 2024.

Financial Statements

News

There is no news available yet.